论文信息 - Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial - 字舞流文

Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial

Young Hak Kim | T. Mitsudomi | M. Satouchi | K. Goto | M. Kondo | K. Azuma | M. Nishio | N. Yamamoto | T. Seto | T. Tamura | K. Nakagawa | T. Hida | Satoshi Watanabe | Y. Takiguchi | K. Hotta | F. Imamura | H. Yoshioka | T. Asakawa | Tomohiro Tanaka | H. Nokihara | T. Shukuya | T. Kozuki | Ryoichi Asabe | Y. H. Kim